Alaunos Therapeutics, Inc.

Alaunos Therapeutics (TCRT) filed a delisting notice on April 15, 2026, marking a material corporate event requiring immediate context. Our 90-day snapshot detected one red-flag 8-K with no cyber incidents, but this single event warrants deeper analysis of the company's financial trajectory and regulatory standing. The full $49 Report contextualizes this delisting filing against 12 months of financing history, dilution risk scoring, and AI-detected distress signals that may have preceded the announcement. The full $49 Report adds detailed 8-K analysis, historical capital structure changes, and early-warning risk markers to help you assess the severity and timeline of this development.